header logo image


Page 9«..78910

Archive for December, 2024

Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments – The Wall Street Journal

Friday, December 6th, 2024

Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments  The Wall Street Journal

See original here:
Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments - The Wall Street Journal

Read More...

Sanders Slams Greed That Led to Surge in Obesity, Diabetes in US – The Well News

Friday, December 6th, 2024

Sanders Slams Greed That Led to Surge in Obesity, Diabetes in US  The Well News

Read the original here:
Sanders Slams Greed That Led to Surge in Obesity, Diabetes in US - The Well News

Read More...

New Study Teases Out Chocolate and Diabetes Connection – Medpage Today

Friday, December 6th, 2024

New Study Teases Out Chocolate and Diabetes Connection  Medpage Today

Read more:
New Study Teases Out Chocolate and Diabetes Connection - Medpage Today

Read More...

Diabetes tool turned wellness trend: Is a glucose monitor right for you? – KARE11.com

Friday, December 6th, 2024

Diabetes tool turned wellness trend: Is a glucose monitor right for you?  KARE11.com

More:
Diabetes tool turned wellness trend: Is a glucose monitor right for you? - KARE11.com

Read More...

Reporter doesnt have diabetes but wore a glucose monitor anyway. Here’s what she learned – CNN

Friday, December 6th, 2024

Reporter doesnt have diabetes but wore a glucose monitor anyway. Here's what she learned  CNN

Originally posted here:
Reporter doesnt have diabetes but wore a glucose monitor anyway. Here's what she learned - CNN

Read More...

Lilly’s Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7% – Investors |…

Friday, December 6th, 2024

Lilly's Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%  Investors | Eli Lilly and Company

See the original post here:
Lilly's Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7% - Investors |...

Read More...

I dont have diabetes, but I wore a glucose monitor for six weeks. Heres what I learned about food (and anxiety) – CNN

Friday, December 6th, 2024

I dont have diabetes, but I wore a glucose monitor for six weeks. Heres what I learned about food (and anxiety)  CNN

See the rest here:
I dont have diabetes, but I wore a glucose monitor for six weeks. Heres what I learned about food (and anxiety) - CNN

Read More...

Higher niacin levels linked to lower cardiovascular risk, but not in those with diabetes – Healio

Friday, December 6th, 2024

Higher niacin levels linked to lower cardiovascular risk, but not in those with diabetes  Healio

Here is the original post:
Higher niacin levels linked to lower cardiovascular risk, but not in those with diabetes - Healio

Read More...

This Type Of Chocolate Could Reduce Type 2 Diabetes Risk By 21% – NDTV

Friday, December 6th, 2024

This Type Of Chocolate Could Reduce Type 2 Diabetes Risk By 21%  NDTV

More:
This Type Of Chocolate Could Reduce Type 2 Diabetes Risk By 21% - NDTV

Read More...

New Study Links Safer BPA Alternatives to Obesity, Diabetes, and Hormone Disruption – SciTechDaily

Friday, December 6th, 2024

New Study Links Safer BPA Alternatives to Obesity, Diabetes, and Hormone Disruption  SciTechDaily

See the article here:
New Study Links Safer BPA Alternatives to Obesity, Diabetes, and Hormone Disruption - SciTechDaily

Read More...

Turns Out Dark Chocolate Has a Health Benefit That’s Shockingly GreatAnd Totally Unexpected – Well+Good

Friday, December 6th, 2024

Turns Out Dark Chocolate Has a Health Benefit That's Shockingly GreatAnd Totally Unexpected  Well+Good

Excerpt from:
Turns Out Dark Chocolate Has a Health Benefit That's Shockingly GreatAnd Totally Unexpected - Well+Good

Read More...

Harnessing the Power of the Immune System for Breast Cancer Treatment – Breast Cancer Research Foundation

Friday, December 6th, 2024

Harnessing the Power of the Immune System for Breast Cancer Treatment  Breast Cancer Research Foundation

Continue reading here:
Harnessing the Power of the Immune System for Breast Cancer Treatment - Breast Cancer Research Foundation

Read More...

Neutrophil diversity and function in health and disease – Nature.com

Friday, December 6th, 2024

Neutrophil diversity and function in health and disease  Nature.com

View original post here:
Neutrophil diversity and function in health and disease - Nature.com

Read More...

The 5 Best Teas to Support Your Immune System This Cold & Flu Season – EatingWell

Friday, December 6th, 2024

The 5 Best Teas to Support Your Immune System This Cold & Flu Season  EatingWell

View original post here:
The 5 Best Teas to Support Your Immune System This Cold & Flu Season - EatingWell

Read More...

Study Examines Neoantigen Landscapes and Their Role in Immunotherapy Efficacy – Consult QD

Friday, December 6th, 2024

Study Examines Neoantigen Landscapes and Their Role in Immunotherapy Efficacy  Consult QD

Originally posted here:
Study Examines Neoantigen Landscapes and Their Role in Immunotherapy Efficacy - Consult QD

Read More...

Engineered immune cells may be able to tame inflammation – Medical Xpress

Friday, December 6th, 2024

Engineered immune cells may be able to tame inflammation  Medical Xpress

Go here to read the rest:
Engineered immune cells may be able to tame inflammation - Medical Xpress

Read More...

Opioids interfere with cancer immunotherapy, but another type of drug could help – Medical Xpress

Friday, December 6th, 2024

Opioids interfere with cancer immunotherapy, but another type of drug could help  Medical Xpress

Link:
Opioids interfere with cancer immunotherapy, but another type of drug could help - Medical Xpress

Read More...

Hybrid model of tumor growth, angiogenesis and immune response yields strategies to improve antiangiogenic therapy – Nature.com

Friday, December 6th, 2024

Hybrid model of tumor growth, angiogenesis and immune response yields strategies to improve antiangiogenic therapy  Nature.com

See more here:
Hybrid model of tumor growth, angiogenesis and immune response yields strategies to improve antiangiogenic therapy - Nature.com

Read More...

RANKL cytokine restores thymus cells in old mice, reducing tumor growth and improving T cell immune response – Fierce Biotech

Friday, December 6th, 2024

RANKL cytokine restores thymus cells in old mice, reducing tumor growth and improving T cell immune response  Fierce Biotech

More:
RANKL cytokine restores thymus cells in old mice, reducing tumor growth and improving T cell immune response - Fierce Biotech

Read More...

Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in…

Friday, December 6th, 2024

Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in patients with MASLD  Nature.com

Follow this link:
Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in...

Read More...

Page 9«..78910


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick